Graphene-based biosensors incorporated in arrays of microneedles are emerging as an alternative to hypodermic needles and could be the next generation of blood sampling devices.
Personalized medicine for diseases that affect the central nervous system requires renewed focus on visualising the behaviour of drugs in the brain.
Hybridizing biofabrication processes will lead us to superior “living” tissue and organ substitutes that can be used to treat patients in lieu of donor grafts and metal and plastic devices.
Nanotechnology is poised to revolutionize the diagnosis and treatment of patients with type 1 diabetes.
A new study explores how metal nanoparticles designed for new X-ray imaging technologies can improve the diagnosis of diseases, as well as understand the underlying cellular processes.
Cutting-edge fluorine-19 imaging of inflammation extends the frontiers of MRI.
Micro- and nanoparticle-based drug delivery systems are revolutionizing medicine, from minimizing the toxicity of therapeutics to improving their efficacy.
Researchers at Houston Methodist Research Institute discuss how quantitative, non-invasive imaging can aid in developing novel tools for diagnosis and therapy.
Antibiotic-resistant bacteria are becoming a major global threat. Novel antibacterial nanomaterials offer a solution.
A nanocarrier that can deliver siRNA into the lungs is investigated for the treatment of severe asthma and other lung diseases.